Abstract
Stroke is the most common primary neurologic problem that leads to inpatient hospitalization. Understanding vascular neuroanatomy is essential for localizing stroke to a specific site in the brain, but vascular syndromes can be recognized quickly at the bedside with knowledge of common patterns of anterior circulation strokes, posterior circulation strokes, lacunar syndromes, cerebral venous sinus thromboses, and intracerebral hemorrhages. Mimics of stroke include the acute confusional state, focal neuropathies, re-expression of old strokes, and psychogenic disorders. Neuroimaging studies are essential to confirm the presence of a stroke, define its etiology, and determine appropriate treatment. Noncontrast head CT is the most important study when intravenous thrombolysis is being considered, though it is insensitive to most acute infarctions. Diffusion-weighted MRI is the imaging procedure that is most sensitive to ischemic stroke. Vascular imaging studies of the cervical and cerebral vasculature help to define the cause of a stroke. Intravenous thrombolysis is a potentially life-saving treatment that must be performed as soon as possible using a specific protocol. Secondary stroke prevention includes management of blood pressure and hyperlipidemia and selection of appropriate antiplatelet agents or anticoagulants. Carotid endarterectomy and stenting are potential treatment options for patients with strokes derived from the carotid artery. Intracranial hemorrhage is a life-threatening emergency that may be impossible to treat effectively in many cases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke. Stroke. 2007;38:1655–711.
Amarenco P, Labreuche J, Lavallee P, Touboul P-J. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke. 2004;35:2902–9.
Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355–65.
Azzimondi G, Bassein L, Nonino F, et al. Fever in acute stroke worsens prognosis: a prospective study. Stroke. 1995;26:2040–3.
Baird TA, Parsons MW, Phanh T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34:2208–14.
Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med. 1998;339:1415–25.
Barreto AD, Martin-Schild S, Hallevi H, et al. Thrombolytic therapy for patients who wake-up with stroke. Stroke. 2009;40:827–32.
Barth A, Bogousslavsky J, Caplan LR. Thalamic infarcts and hemorrhages. In: Bogousslavsky J, Caplan L, editors. Stroke syndromes. 2nd ed. Cambridge: Cambridge University Press; 2001. p. 461–8.
Brazzelli M, Chappell FM, Miranda H, et al. Diffusion-weighted imaging and diagnosis of transient ischemic attack. Ann Neurol. 2014;75:67–76.
Broderick JP, Brott T, Duldner J, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987–93.
Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults. Stroke. 2007;38:2001–23.
Brott TG, Hobson RW, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11–23.
Bushnell CD, Goldstein LB. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke. 2000;31:3067–78.
Caplan LR. “Top of the basilar” syndrome. Neurology. 1980;30:72–9.
Caplan LR. Caplan’s stroke: a clinical approach. 3rd ed. Boston: Butterworth Heineman; 2000.
Caplan LR, Kelly M, Kase CS, et al. Infarcts of the inferior division of the right middle cerebral artery: mirror image of Wernicke’s aphasia. Neurology. 1986;36:1015–20.
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329–39.
Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368:1092–100.
Chambers BR, Donnan G (2005) Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev (4):CD001923
Cianfoni A, Caulo M, Cerase A, et al. Seizure-induced brain lesions: a wide spectrum of variably reversible MRI abnormalities. Eur J Radiol. 2013;82:1964–72.
Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–51.
Connolly SJ, Eikelboom J, Joyner C, et al. Abixaban in patients with atrial fibrillation. N Engl J Med. 2011;364:806–17.
Corvol JC, Bouzamondo A, Sirol M, et al. Differential effects of lipid-lowering therapies on stroke prevention. A meta-analysis of randomized trials. Arch Intern Med. 2003;163:669–76.
Cronin CA, Shah N, Morovati T, Hermann LD, Sheth KN. No increased risk of symptomatic intracerebral hemorrhage after thrombolysis in patients with European Cooperative Acute Stroke Study (ECASS) exclusion criteria. Stroke. 2012;43:1684–6.
Del Zoppo G, Saver JL, Jauch EC, Adams HP. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40:2945–8.
DePippo KL, Holas MA, Reding MJ. Validation of the 3-oz water swallow test for aspiration following stroke. Arch Neurol. 1992;49:1259–61.
Devinsky O, Bear D, Volpe BT. Confusional stats following posterior cerebral artery infarction. Arch Neurol. 1988;45:160–3.
Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention os stroke. J Neurol Sci. 1996;143:1–13.
Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331–7.
Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack. Stroke. 2009;40:2276–93.
Fisher CM. Lacunar strokes and infarcts: a review. Neurology. 1982;32:871–6.
Flaherty ML, Haverbusch M, Sekar P, et al. Long-term mortality after intracerebral hemorrhage. Neurology. 2006;66:1182–6.
Gass A, Szabo K, Behrens S, Rossmanith C, Hennerici M. A diffusion-weighted MRI study of acute ischemic distal arm paresis. Neurology. 2001;57:1589–94.
Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007;6:1063–72.
Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981–92.
Grotta JC, Chiu D, Lu M, et al. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke. 1999;30:1528–33.
Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768–74.
Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.
Hand PJ, Kwan J, Lindley RI, Dennis MS, Wardlaw JM. Distinguishing between stroke and mimic at the bedside: the Brain Attack Study. Stroke. 2006;37:769–75.
Hankey GJ, Warlow CP, Sellar RJ. Cerebral angiographic risk in mild cerebrovascular disease. Stroke. 1990;21:209–22.
Hass WK, Easton JD, Adams HP, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med. 1989;321:501–7.
Hawryluk GWJ, Austin JW, Furlan JC, et al. Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk. J Thromb Haemost. 2010;8:1500–8.
Hemphill JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC. A simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891–7.
Hickey M, Gatien M, Taljaard M, et al. Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department. Circulation. 2013;128:360–4.
Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947.
Jorgensen HS, Nakayma H, Raaschou HO, et al. Outcome and time course of recovery in stroke. Part II; time course of recovery. The Copenhagen Stroke Study. Arch Phys Med Rehabil. 1995;76:406–12.
Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology. 2001;57:1603–10.
Kasner SE, Demchuk AM, Berrouschot J, et al. Predictors of fatal brain edema in massive hemispheric stroke. Stroke. 2001;32:2117–23.
Kidwell CS, Chalela JA, Saver JL, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA. 2004;292:1823–30.
Kumar S, Goddeau RP, Selim MH, et al. Atraumatic convexal subarachnoid hemorrhage. Clinical presentation, imaging patterns, and etiologies. Neurology. 2010;74:893–9.
Lansberg MG, Thijs VN, O’Brien MW, et al. Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke. AJNR Am J Neuroradiol. 2001;22:637–44.
Majeed A, Kim YK, Roberts RS, Holmstrom M, Schulman S. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke. 2010;51:2860–6.
Mayberg MR, Wilson SE, Yatsu F, et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis: Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA. 1991;266:3289–94.
Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–97.
Messe SR, Silverman IE, Kizer JR, et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004;62:1042–50.
Mesulam M, Waxman SG, Geschwind N, Sabin TD. Acute confusional states with right middle cerebral artery infarctions. J Neurol Neurosurg Psychiatry. 1976;39:84–9.
Mohr JP, Thompson JL, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444–51.
Muresan IP, Favrole P, Levy P, et al. Very early neurologic improvement after intravenous thrombolysis. Arch Neurol. 2010;67:1323–8.
NASCET Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–53.
Neau J-P, Bogousslavsky J. Superficial middle cerebral artery syndromes. In: Bogousslavsky J, Caplan L, editors. Stroke syndromes. 2nd ed. Cambridge: Cambridge University Press; 2001. p. 405–27.
Oliveira-Filho J, Silva SCS, Trabuco CC, et al. Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology. 2003;61:1047–51.
Paolucci S, Antonucci G, Grasso M, et al. Early versus delayed inpatient stroke rehabilitation: a matched comparison conducted in Italy. Arch Phys Med Rehabil. 2000;81:695–700.
Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–91.
Pearson AC, Labovitz AJ, Tatineni S, Gomez CR. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol. 1991;17:66–72.
Poli D, Antonucci E, Dentali F, et al. Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE study. Neurology. 2014;82:1020–6.
Quinette P, Berengere G, Dayan J, et al. What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain. 2006;129:1640–58.
Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004;363:915–24.
Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke. 2006;37:577–617.
Sacco RL, Diener HC, Yusuf S, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359:1238–51.
Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370:2478–86.
Schaefer PW. Applications of DWI in clinical neurology. J Neurol Sci. 2001;186:S25–35.
Schlaug G, Benfield A, Baird AE, et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology. 1999;53:1528–55.
Schneider R, Gautier JC. Leg weakness due to stroke. Site of lesions, weakness patterns and causes. Brain. 1994;117:347–54.
SPARCL Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549–59.
Stead LG, Gilmore RM, Bellolio MF, Rabinstein AA, Decker WW. Percutaneous clot removal devices in acute ischemic stroke. Arch Neurol. 2008;65:1024–30.
Tayal AH, Tian M, Kelly KM, et al. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic stroke. Neurology. 2008;71:1696–701.
Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet. 1974;304:81–4.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. New Engl J Med. 1995;333:1581–7.
Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215–22.
Vertinsky AT, Schwartz NE, Fischbein NJ, et al. Comparison of multidetector CT angiography and MR imaging of cervical artery dissection. AJNR Am J Neuroradiol. 2008;29:1753–60.
Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol. 1995;37:231–41.
Wardlaw JM, Mielke O. Early signs of brain infarction at CT: observer reliability and outcome after thrombolytic treatment—systematic review. Radiology. 2005;235:444–53.
Yadav JS, Wholey MH, Kuntz RE, Fayad P. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493–501.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Tarulli, A. (2016). Stroke. In: Neurology. Springer, Cham. https://doi.org/10.1007/978-3-319-29632-6_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-29632-6_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29630-2
Online ISBN: 978-3-319-29632-6
eBook Packages: MedicineMedicine (R0)